Musculin and TCF21 coordinate the maintenance of myogenic regulatory factor expression levels during mouse craniofacial development

Development

Volumn 139, Issue 5, 2012, Pages 958-967

  Moncaut, Natalia ^a   Cross, Joe W ^a   Siligan, Christine ^a   Keith, Annette ^a   Taylor, Kevin ^a   Rigby, Peter W J ^a   Carvajal, Jaime J ^a,b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSIDAD PABLO DE OLAVIDE   (Spain)

Author keywords

Craniofacial; Msc; Myf5; Myod; Myogenesis; Tcf21

Indexed keywords

MUSCLE PROTEIN; MUSCULIN; MYOD PROTEIN; MYOGENIC FACTOR; MYOGENIC FACTOR 5; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 21; UNCLASSIFIED DRUG;

ANATOMICAL VARIATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; BRANCHIAL ARCH; CELL LINEAGE; CONTROLLED STUDY; CRANIOFACIAL DEVELOPMENT; E BOX ELEMENT; EMBRYO; ENHANCER REGION; GENE ACTIVATION; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; MOUSE; MUSCLE DEVELOPMENT; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; STEM CELL; TRANSCRIPTION REGULATION;

ANIMALS; BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; BODY PATTERNING; BRANCHIAL REGION; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE REGULATORY NETWORKS; HUMANS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; MUSCLE, SKELETAL; MUTATION; MYOD PROTEIN; MYOGENIC REGULATORY FACTOR 5; REGULATORY SEQUENCES, NUCLEIC ACID; STEM CELLS; T-BOX DOMAIN PROTEINS; TRANSCRIPTION FACTORS;

MUS;

EID: 84856737960     PISSN: 09501991     EISSN: 14779129     Source Type: Journal    
DOI: 10.1242/dev.068015     Document Type: Article

References (54)

1. Asakura, A., Lyons, G. E. and Tapscott, S. J. (1995). The regulation of MyoD gene expression: conserved elements mediate expression in embryonic axial muscle. Dev. Biol. 171, 386-398.
2. Bajard, L., Relaix, F., Lagha, M., Rocancourt, D., Daubas, P. and Buckingham, M. E. (2006). A novel genetic hierarchy functions during hypaxial myogenesis: Pax3 directly activates Myf5 in muscle progenitor cells in the limb. Genes Dev. 20, 2450-2464.
3. Braun, T., Bober, E., Rudnicki, M. A., Jaenisch, R. and Arnold, H. H. (1994). MyoD expression marks the onset of skeletal myogenesis in Myf-5 mutant mice. Development 120, 3083-3092.
4. Buchberger, A., Nomokonova, N. and Arnold, H. H. (2003). Myf5 expression in somites and limb buds of mouse embryos is controlled by two distinct distal enhancer activities. Development 130, 3297-3307.
5. Carvajal, J. J. and Rigby, P. W. J. (2010). Regulation of gene expression in vertebrate skeletal muscle. Exp. Cell Res. 316, 3014-3018.
6. Carvajal, J. J., Cox, D., Summerbell, D. and Rigby, P. W. J. (2001). A BAC transgenic analysis of the Mrf4/Myf5 locus reveals interdigitated elements that control activation and maintenance of gene expression during muscle development. Development 128, 1857-1868.
7. Carvajal, J. J., Keith, A. and Rigby, P. W. J. (2008). Global transcriptional regulation of the locus encoding the skeletal muscle determination genes Mrf4 and Myf5. Genes Dev. 22, 265-276.
8. Chen, J. C. and Goldhamer, D. J. (2004). The core enhancer is essential for proper timing of MyoD activation in limb buds and branchial arches. Dev. Biol. 265, 502-512.
9. Chen, J. C., Love, C. M. and Goldhamer, D. J. (2001). Two upstream enhancers collaborate to regulate the spatial patterning and timing of MyoD transcription during mouse development. Dev. Dyn. 221, 274-288.
10. Chen, J. C., Ramachandran, R. and Goldhamer, D. J. (2002). Essential and redundant functions of the MyoD distal regulatory region revealed by targeted mutagenesis. Dev. Biol. 245, 213-223.
11. Dong, F., Sun, X., Liu, W., Ai, D., Klysik, E., Lu, M. F., Hadley, J., Antoni, L., Chen, L., Baldini, A., Francis-West, P. and Martin, J. F. (2006). Pitx2 promotes development of splanchnic mesoderm-derived branchiomeric muscle. Development 133, 4891-4899.
12. Dubchak, I. and Ryaboy, D. V. (2006). VISTA family of computational tools for comparative analysis of DNA sequences and whole genomes. Methods Mol. Biol. 338, 69-89.
13. Eben-Massari, M., Rivera, R. R., Voland, J. R., Quong, M. W., Breit, T. M., van Dongen, J. J., de Smit, O. and Murre, C. (1998). Characterization of ABF-1, a novel basic helix-loop-helix transcription factor expressed in activated B lymphocytes. Mol. Cell. Biol. 18, 3130-3139.
14. Faerman, A., Goldhamer, D. J., Puzis, R., Emerson, C. P., Jr and Shani, M. (1995). The distal human myoD enhancer sequences direct unique musclespecific patterns of lacZ expression during mouse development. Dev. Biol. 171, 27-38.
15. Familari, M., Vu, D. and Parry, L. J. (2009). Regulation of Rxfp2 (Lgr8) expression in the mouse fetal kidney by the transcription factor Pod1 (Tcf 21). Ann. N. Y. Acad. Sci. 1160, 317-319.
16. Fomin, M., Nomokonova, N. and Arnold, H. H. (2004). Identification of a critical control element directing expression of the muscle-specific transcription factor MRF4 in the mouse embryo. Dev. Biol. 272, 498-509.
17. Funato, N., Ohyama, K., Kuroda, T. and Nakamura, M. (2003). Basic helixloop- helix transcription factor Epicardin/Capsulin/Pod-1 suppresses differentiation by negative regulation of transcription. J. Biol. Chem. 278, 7486-7493.
18. Gilthorpe, J., Vandromme, M., Brend, T., Gutman, A., Summerbell, D., Totty, N. and Rigby, P. W. J. (2002). Spatially specific expression of Hoxb4 is dependent on the ubiquitous transcription factor NFY. Development 129, 3887-3889.
19. Goldhamer, D. J., Brunk, B. P., Faerman, A., King, A., Shani, M. and Emerson, C. P., Jr (1995). Embryonic activation of the myoD gene is regulated by a highly conserved distal control element. Development 121, 637-649.
20. Hadchouel, J., Tajbakhsh, S., Primig, M., Chang, T. H., Daubas, P., Rocancourt, D. and Buckingham, M. (2000). Modular long-range regulation of Myf5 reveals unexpected heterogeneity between skeletal muscles in the mouse embryo. Development 127, 4455-4467.
21. Hadchouel, J., Carvajal, J. J., Daubas, P., Bajard, L., Chang, T., Rocancourt, D., Cox, D., Summerbell, D., Tajbakhsh, S., Rigby, P. W. J. and Buckingham, M. (2003). Analysis of a key regulatory region upstream of the Myf5 gene reveals multiple phases of myogenesis, orchestrated at each site by a combination of elements dispersed throughout the locus. Development 130, 3415-3426.
22. Heinemeyer, T., Wingender, E., Reuter, I., Hermjakob, H., Kel, A. E., Kel, O. V., Ignatieva, E. V., Ananko, E. A., Podkolodnaya, O. A., Kolpakov, F. A., Podkolodny, N. L. and Kolchanov, N. A. (1998). Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res. 26, 362-367.
23. Hong, C. Y., Gong, E. Y., Kim, K., Suh, J. H., Ko, H. M., Lee, H. J., Choi, H. S. and Lee, K. (2005). Modulation of the expression and transactivation of androgen receptor by the basic helix-loop-helix transcription factor Pod-1 through recruitment of histone deacetylase 1. Mol. Endocrinol. 19, 2245-2257.
24. Kassar-Duchossoy, L., Gayraud-Morel, B., Gomès, D., Rocancourt, D., Buckingham, M., Shinin, V. and Tajbakhsh, S. (2004). Mrf4 determines skeletal muscle identity in Myf5:Myod double-mutant mice. Nature 431, 466-471.
25. Kaul, A., Köster, M., Neuhaus, H. and Braun, T. (2000). Myf-5 revisited: loss of early myotome formation does not lead to a rib phenotype in homozygous Myf- 5 mutant mice. Cell 102, 17-19.
26. Kelly, R. G., Jerome-Majewska, L. A. and Papaioannou, V. E. (2004). The del22q11.2 candidate gene Tbx1 regulates branchiomeric myogenesis. Hum. Mol. Genet. 13, 2829-2840.
27. Kucharczuk, K. L., Love, C. M., Dougherty, N. M. and Goldhamer, D. J. (1999). Fine-scale transgenic mapping of the MyoD core enhancer: MyoD is regulated by distinct but overlapping mechanisms in myotomal and nonmyotomal muscle lineages. Development 126, 1957-1965.
28. Lu, J., Richardson, J. A. and Olson, E. N. (1998). Capsulin: a novel bHLH transcription factor expressed in epicardial progenitors and mesenchyme of visceral organs. Mech. Dev. 73, 23-32.
29. Lu, J., Webb, R., Richardson, J. A. and Olson, E. N. (1999). MyoR: a musclerestricted basic helix-loop-helix transcription factor that antagonizes the actions of MyoD. Proc. Natl. Acad. Sci. USA 96, 552-557.
30. Lu, J. R., Bassel-Duby, R., Hawkins, A., Chang, P., Valdez, R., Wu, H., Gan, L., Shelton, J. M., Richardson, J. A. and Olson, E. N. (2002). Control of facial muscle development by MyoR and capsulin. Science 298, 2378-2381.
31. Miyagishi, M., Hatta, M., Ohshima, T., Ishida, J., Fujii, R., Nakajima, T. and Fukamizu, A. (2000). Cell type-dependent transactivation or repression of mesoderm-restricted basic helix-loop-helix protein, POD-1/Capsulin. Mol. Cell. Biochem. 205, 141-147.
32. Nathan, E., Monovich, A., Tirosh-Finkel, L., Harrelson, Z., Rousso, T., Rinon, A., Harel, I., Evans, S. M. and Tzahor, E. (2008). The contribution of Islet1- expressing splanchnic mesoderm cells to distinct branchiomeric muscles reveals significant heterogeneity in head muscle development. Development 135, 647-657.
33. Noden, D. M., Marcucio, R., Borycki, A. G. and Emerson, C. P., Jr (1999). Differentiation of avian craniofacial muscles: I. Patterns of early regulatory gene expression and myosin heavy chain synthesis. Dev. Dyn. 216, 96-112.
34. Nowotschin, S., Liao, J., Gage, P. J., Epstein, J. A., Campione, M. and Morrow, B. E. (2006). Tbx1 affects asymmetric cardiac morphogenesis by regulating Pitx2 in the secondary heart field. Development 133, 1565-1573.
35. Patapoutian, A., Miner, J. H., Lyons, G. E. and Wold, B. (1993). Isolated sequences from the linked Myf-5 and MRF4 genes drive distinct patterns of muscle-specific expression in transgenic mice. Development 118, 61-69.
36. Ribas, R., Moncaut, N., Siligan, C., Taylor, K., Cross, J. W., Rigby, P. W. J. and Carvajal, J. J. (2011). Members of the TEAD family of transcription factors regulate the expression of Myf5 in ventral somitic compartments. Dev. Biol. 355, 372-380.
37. Robb, L., Hartley, L., Wang, C. C., Harvey, R. P. and Begley, C. G. (1998). musculin: a murine basic helix-loop-helix transcription factor gene expressed in embryonic skeletal muscle. Mech. Dev. 76, 197-201.
38. Rudnicki, M. A., Braun, T., Hinuma, S. and Jaenisch, R. (1992). Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell 71, 383-390.
39. Rudnicki, M. A., Schnegelsberg, P. N., Stead, R. H., Braun, T., Arnold, H. H. and Jaenisch, R. (1993). MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 75, 1351-1359.
40. Sambasivan, R., Gayraud-Morel, B., Dumas, G., Cimper, C., Paisant, S., Kelly, R. G. and Tajbakhsh, S. (2009). Distinct regulatory cascades govern extraocular and pharyngeal arch muscle progenitor cell fates. Dev. Cell 16, 810-821.
41. Shih, H. P., Gross, M. K. and Kioussi, C. (2007). Cranial muscle defects of Pitx2 mutants result from specification defects in the first branchial arch. Proc. Natl. Acad. Sci. USA 104, 5907-5912.
42. Summerbell, D., Ashby, P. R., Coutelle, O., Cox, D., Yee, S. and Rigby, P. W. J. (2000). The expression of Myf5 in the developing mouse embryo is controlled by discrete and dispersed enhancers specific for particular populations of skeletal muscle precursors. Development 127, 3745-3757.
43. Swaminathan, S., Ellis, H. M., Waters, L. S., Yu, D., Lee, E. C., Court, D. L. and Sharan, S. K. (2001). Rapid engineering of bacterial artificial chromosomes using oligonucleotides. Genesis 29, 14-21.
44. Tajbakhsh, S., Rocancourt, D., Cossu, G. and Buckingham, M. (1997). Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. Cell 89, 127-138.
45. Tamura, M., Kanno, Y., Chuma, S., Saito, T. and Nakatsuji, N. (2001). Pod- 1/Capsulin shows a sex-and stage-dependent expression pattern in the mouse gonad development and represses expression of Ad4BP/SF-1. Mech. Dev. 102, 135-144.
46. Tapscott, S. J., Lassar, A. B. and Weintraub, H. (1992). A novel myoblast enhancer element mediates MyoD transcription. Mol. Cell. Biol. 12, 4994-5003.
47. Teboul, L., Hadchouel, J., Daubas, P., Summerbell, D., Buckingham, M. and Rigby, P. W. J. (2002). The early epaxial enhancer is essential for the initial expression of the skeletal muscle determination gene Myf5 but not for subsequent, multiple phases of somitic myogenesis. Development 129, 4571-4580.
48. Tzahor, E., Kempf, H., Mootoosamy, R. C., Poon, A. C., Abzhanov, A., Tabin, C. J., Dietrich, S. and Lassar, A. B. (2003). Antagonists of Wnt and BMP signaling promote the formation of vertebrate head muscle. Genes Dev. 17, 3087-3099.
49. von Scheven, G., Bothe, I., Ahmed, M. U., Alvares, L. E. and Dietrich, S. (2006). Protein and genomic organisation of vertebrate MyoR and Capsulin genes and their expression during avian development. Gene Expr. Patterns 6, 383-393.
50. Yee, S. P. and Rigby, P. W. J. (1993). The regulation of myogenin gene expression during the embryonic development of the mouse. Genes Dev. 7, 1277-1289.
51. Yu, L., Mikloucich, J., Sangster, N., Perez, A. and McCormick, P. J. (2003). MyoR is expressed in nonmyogenic cells and can inhibit their differentiation. Exp. Cell Res. 289, 162-173.
52. Yu, L., Sangster, N., Perez, A. and McCormick, P. J. (2004). The bHLH protein MyoR inhibits the differentiation of early embryonic endoderm. Differentiation 72, 341-347.
53. Zacharias, A. L., Lewandoski, M., Rudnicki, M. A. and Gage, P. J. (2011). Pitx2 is an upstream activator of extraocular myogenesis and survival. Dev. Biol. 349, 395-405.
54. Zweigerdt, R., Braun, T. and Arnold, H. H. (1997). Faithful expression of the Myf-5 gene during mouse myogenesis requires distant control regions: a transgene approach using yeast artificial chromosomes. Dev. Biol. 192, 172-180.